Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1900139Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Internal Medicine
NIH Funding · FY2024
Linked Award Amount
$1.1M
Full award amounts, FY2024
Award Records
3
Records listing this PI
Award-Linked Rank
#13,907
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2024 award records by amount
NIH award records listing Chinthalapally V. Rao as a PI. Multi-PI records show the full award amount for context.
- 75N91024D00005-0-759102400002-1N01TO TITLE: A NOVEL MRNA VACCINE TO PREVENT TRIPLE NEGATIVE BREAST CANCERIDIQ TITLE: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMARKERS$764.9Kaward amount
- 1UG3CA290310-01UG3Discovery and Development of Natural Products for Interception of CRC$303.9Kaward amount
- 75N91024D00005-0-759102400001-1N01Contract Orientation and Kickoff Meeting$3.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Chinthalapally V. Rao as a PI.
FY2024 award administered by University of Oklahoma Health Sciences Center (OK).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of Oklahoma Health Sciences Center
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding